Foley Hoag LLP represented Vergent Bioscience, Inc. on the deal. Vergent Bioscience, Inc. (“Vergent”), a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced a $21.5 million Series...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, closed a collaboration agreement with...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised B2W Software on the deal. B2W Software, a leading provider of estimating and operations solutions for the heavy civil construction industry, announced its sale...
You must be a Standard 1 Year member to access this content.
Foley Hoag represented FX HedgePool on the deal. FX HedgePool, a provider of a peer-to-peer matching platform for institutional foreign exchange transactions, announced its $8 million Series...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Hecate Energy on the deal. Hecate Energy announced the obtaining of its final permit for the siting, construction and operation of the Cider Solar...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised SparkCharge on the deal. SparkCharge, the world’s first mobile EV charging network, announced a $23 million Series A funding co-led by Tale Venture Partners...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented Ginkgo Bioworks, Inc. on the deal. Ginkgo Bioworks, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, closed a collaboration agreement with...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented Satellite Bio on the deal. Satellite Bio, a regenerative medicine company raised $110 million in Seed and Series A funding. The recent Series A...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented NODAR Inc. on the deal. NODAR Inc., a maker of 3D vision software for autonomous vehicles, announced a $12 million Series A funding...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented The Valens Company on the deal. The Valens Company (TSX: VLNS; Nasdaq: VLNS), a leading manufacturer of cannabis products, announced its underwritten “bought...
You must be a Standard 1 Year member to access this content.
Stoic Advisory Inc. and Solidum Capital Advisors are acting as financial advisor to Cresco Labs. A.G.P./Alliance Global Partners provided a fairness opinion to Cresco Labs’ Board...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented Thermo Fisher Scientific Inc. on the acquisition. Thermo Fisher Scientific Inc. (NYSE: TMO), a world leader in serving science, has acquired Max Analytical Technologies, a...
You must be a Standard 1 Year member to access this content.
